A new engineered gene-editing system, proven in bacteria and showing promise for use in plants, animals and humans, addresses ...
Caribou Biosciences is stopping work on its two remaining cancer cell therapies and exploring strategic alternatives for the ...
The Berkeley gene-editing company will wind down its lymphoma and myeloma studies and explore a potential sale.
CRISPR halves model-generation time and cuts costs by ~40%, while automation, aquatic models, genetic testing and cryobanking boost efficiency and client retention.Dublin, Oct. 07, 2026 (GLOBE ...
Despite having an allogeneic cell therapy prospect that’s ready for late-stage testing in lymphoma, Caribou couldn’t secure ...
Pharmaceutical Technology on MSN
CAR-T specialist Caribou culls pipeline and seeks exit deal
Despite Nobel Prize origins, Caribou has succumbed to a sector shifting its focus to in vivo CAR-T approaches.
Caribou Biosciences is shutting down after failing to raise the money necessary to fund a late-stage clinical trial of its off-the-shelf CAR-T therapy for lymphoma.
The World Health Organization released its first guidelines addressing the sharp rise in obesity among children and adolescents ...
India can become a science-driven, globally impactful nation by liberating labs, expanding education, and streamlining regulation.
Cornell researchers have built a smaller gene-editing system that can place large pieces of DNA at a chosen site in bacteria, ...
The 2026 Nobel Prize for Chemistry has been awarded to Henri Kagan of Paris-Sud University and Kenso Soai of the Tokyo University of Science for their work exploring the fundamental geometry of ...
Anthropicによると、Claudeエージェントは当初、逆転写酵素の可能性がある配列を20万件以上特定した。そこから新規とみられる数千件を選び出してさらに絞り込み、最終的に「異例の」逆転写酵素の一群を発見したのである。この一群には、CRISPRに ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results